CAN-03

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCAN-03
Drug Alias Nameanti-IL1RAP antibody (Cantargia)CAN-xxanti-IL1RAP mAb (Cantargia)CAN-03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-1 receptor accessory protein inhibitors
TargetsInterleukin-1 receptor accessory protein
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCantargia Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCantargia Ab
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A